Leerink Swann believes that Omnicare's efforts to raise its customer retention rates and cut costs are starting to bear fruit. The firm thinks the stock provides an attractive long-term investment opportunity and it maintains an Outperform rating. :theflyonthewall.com
News For OCR From The Last 14 Days
Check below for free stories on OCR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
